Skip to content
healthcare.dev

ROSUVASTATIN CALCIUM

NDC 71610-793, ROSUVASTATIN CALCIUM, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-793
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207752
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-793 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROSUVASTATIN CALCIUM40 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
71610-793-157161007931515 TABLET in 1 BOTTLE (71610-793-15)
71610-793-457161007934545 TABLET in 1 BOTTLE (71610-793-45)
71610-793-607161007936090 TABLET in 1 BOTTLE (71610-793-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/113160c7-7b41-5395-e063-6394a90a1e15

Use it

Look up 71610-793 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-793 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-793. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.